These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34525006)

  • 1. Non-IFNγ Whole Blood Cytokine Responses to Mycobacterium tuberculosis Antigens in HIV-exposed Infants.
    Anterasian C; Warr AJ; Lacourse SM; Kinuthia J; Richardson BA; Nguyen FK; Matemo D; Maleche-Obimbo E; John Stewart GC; Hawn TR
    Pediatr Infect Dis J; 2021 Oct; 40(10):922-929. PubMed ID: 34525006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CD4+ TNF+ monofunctional memory T-cell response to BCG vaccination is associated with Mycobacterium tuberculosis infection in infants exposed to HIV.
    Warr AJ; Anterasian C; Shah JA; De Rosa SC; Nguyen FK; Maleche-Obimbo E; Cranmer LM; Matemo D; Mecha J; Kinuthia J; LaCourse SM; John-Stewart GC; Hawn TR
    EBioMedicine; 2022 Jun; 80():104023. PubMed ID: 35533496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal HIV Status and Risk of Infant Mycobacterium tuberculosis Infection as Measured by Tuberculin Skin Test.
    Mecha J; Escudero JN; Richardson BA; Maleche-Obimbo E; Matemo D; Kinuthia J; John-Stewart G; LaCourse SM
    Pediatr Infect Dis J; 2024 Mar; 43(3):250-256. PubMed ID: 37991383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
    Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
    Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infant TB Infection Prevention Study (iTIPS): a randomised trial protocol evaluating isoniazid to prevent
    LaCourse SM; Richardson BA; Kinuthia J; Warr AJ; Maleche-Obimbo E; Matemo D; Cranmer LM; Escudero JN; Hawn TR; John-Stewart GC
    BMJ Open; 2020 Jan; 10(1):e034308. PubMed ID: 31969368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Borderline QuantiFERON results and the distinction between specific responses and test variability.
    Uzorka JW; Bossink AWJ; Franken WPJ; Thijsen SFT; Leyten EMS; van Haeften AC; Doornenbal G; Boonstra P; Ottenhoff THM; Arend SM
    Tuberculosis (Edinb); 2018 Jul; 111():102-108. PubMed ID: 30029893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Controlled Trial of Isoniazid to Prevent Mycobacterium tuberculosis Infection in Kenyan Human Immunodeficiency Virus-Exposed Uninfected Infants.
    LaCourse SM; Richardson BA; Kinuthia J; Warr AJ; Maleche-Obimbo E; Matemo D; Cranmer LM; Mecha J; Escudero JN; Hawn TR; John-Stewart G
    Clin Infect Dis; 2021 Jul; 73(2):e337-e344. PubMed ID: 32564076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON(®)-TB Gold (+) Kenyan adults without evidence of tuberculosis.
    Walsh DS; Owira V; Polhemus M; Otieno L; Andagalu B; Ogutu B; Waitumbi J; Hawkridge A; Shepherd B; Pau MG; Sadoff J; Douoguih M; McClain JB;
    Vaccine; 2016 May; 34(21):2430-2436. PubMed ID: 27026148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting.
    LaCourse SM; Cranmer LM; Matemo D; Kinuthia J; Richardson BA; Horne DJ; John-Stewart G
    J Acquir Immune Defic Syndr; 2017 May; 75(1):128-136. PubMed ID: 28141782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-γ and IgG responses to Mycobacterium tuberculosis latency antigen Rv2626c differentiate remote from recent tuberculosis infection.
    Amiano NO; Morelli MP; Pellegrini JM; Tateosian NL; Rolandelli A; Seery V; Castello FA; Gallego C; Armitano R; Stupka J; Erschen MA; Ciallella LM; de Casado GC; Cusmano L; Palmero DJ; Iovanna JL; García VE
    Sci Rep; 2020 May; 10(1):7472. PubMed ID: 32366931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the QuantiFERON?-TB Gold In-Tube assay and tuberculin skin test for the diagnosis of Mycobacterium tuberculosis infection in northeastern Thailand.
    Reechaipichitkul W; Pimrin W; Bourpoern J; Prompinij S; Faksri K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):236-44. PubMed ID: 26342121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-Hit
    Adankwah E; Lundtoft C; Güler A; Franken KLMC; Ottenhoff THM; Mayatepek E; Owusu-Dabo E; Phillips RO; Nausch N; Jacobsen M
    Front Immunol; 2019; 10():1518. PubMed ID: 31333654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Human Immunodeficiency Virus and Peripartum Period on Mycobacterium tuberculosis Infection Detection.
    Escudero JN; Mecha J; Richardson BA; Maleche-Obimbo E; Matemo D; Kinuthia J; John-Stewart G; LaCourse SM
    J Infect Dis; 2023 Dec; 228(12):1709-1719. PubMed ID: 37768184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.
    Gupta D; Kumar S; Aggarwal AN; Verma I; Agarwal R
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):95-101. PubMed ID: 22117500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa.
    Kroon EE; Kinnear CJ; Orlova M; Fischinger S; Shin S; Boolay S; Walzl G; Jacobs A; Wilkinson RJ; Alter G; Schurr E; Hoal EG; Möller M
    EBioMedicine; 2020 Nov; 61():103053. PubMed ID: 33038764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.
    Johnson DF; Malone LL; Zalwango S; Mukisa Oketcho J; Chervenak KA; Thiel B; Mayanja-Kizza H; Stein CM; Boom WH; Lancioni CL;
    PLoS One; 2014; 9(5):e96613. PubMed ID: 24796677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.